Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Josephine Tsang, Jeffrey Sum Lung Wong, Gerry Gin Wai Kwok, Bryan Cho Wing Li, Roland Leung, Joanne Chiu, Tan to Cheung & Thomas Yau. (2021) Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib. Expert Review of Gastroenterology & Hepatology 15:6, pages 589-598.
Read now
Read now
Articles from other publishers (3)
Preeti Kulkarni, Parsshava Mehta, Bharati Shriyan, Kalpita Gawit, Vikram Gota & Minal Ghante. 2021. Immunotherapy – A Novel Facet of Modern Therapeutics. Immunotherapy – A Novel Facet of Modern Therapeutics
195
214
.
Imad El Majzoub, Aiham Qdaisat, Kyaw Z. Thein, Myint A. Win, Myat M. Han, Kalen Jacobson, Patrick S. Chaftari, Michael Prejean, Cielito Reyes-Gibby & Sai-Ching J. Yeung. (2019) Adverse Effects of Immune Checkpoint Therapy in Cancer Patients Visiting the Emergency Department of a Comprehensive Cancer Center. Annals of Emergency Medicine 73:1, pages 79-87.
Crossref
Crossref
Paul Zarogoulidis, Evaggelia Athanasiou, Theodora Tsiouda, Dimitrios Hatzibougias, Haidong Huang, Chong Bai, Georgia Trakada, Lemonia Veletza, Anastasios Kallianos, Christoforos Kosmidis, Nikolaos Barbetakis, Dimitrios Paliouras, Aggeliki Rapti, Dimitrios Drougas & Wolfgang Hohenforst-Schmidt. (2017) Immunotherapy “Shock” a case series of PD-L1 100% and pembrolizumab first-line treatment. Respiratory Medicine Case Reports 22, pages 197-202.
Crossref
Crossref